1. Home
  2. PCSA vs TLIH Comparison

PCSA vs TLIH Comparison

Compare PCSA & TLIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

N/A

Current Price

$2.41

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

TLIH

Ten-League International Holdings Limited Ordinary Shares

N/A

Current Price

$0.24

Market Cap

7.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PCSA
TLIH
Founded
2011
1998
Country
United States
Singapore
Employees
N/A
62
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
7.1M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
PCSA
TLIH
Price
$2.41
$0.24
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
39.3K
1.3M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.34
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.24
52 Week High
$8.88
$7.00

Technical Indicators

Market Signals
Indicator
PCSA
TLIH
Relative Strength Index (RSI) 43.95 30.35
Support Level $0.21 N/A
Resistance Level $2.56 $0.52
Average True Range (ATR) 0.33 0.02
MACD -0.05 -0.01
Stochastic Oscillator 25.41 6.84

Price Performance

Historical Comparison
PCSA
TLIH

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

Share on Social Networks: